{"id":5551,"date":"2023-10-13T12:22:38","date_gmt":"2023-10-13T16:22:38","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=5551"},"modified":"2026-04-13T14:31:24","modified_gmt":"2026-04-13T18:31:24","slug":"aptamers-revolutionizing-diagnostics-in-the-next-generation","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/","title":{"rendered":"Aptam\u00e8res : R\u00e9volutionner le Diagnostic dans la Prochaine G\u00e9n\u00e9ration"},"content":{"rendered":"<ul>\n<li>Les aptam\u00e8res sont des mol\u00e9cules synth\u00e9tiques \u00e0 brin simple d'ADN, d'ARN ou de peptides, dot\u00e9es d'une grande sp\u00e9cificit\u00e9 et d'une forte affinit\u00e9 pour un large \u00e9ventail de mol\u00e9cules cibles, ce qui les rend pr\u00e9cieux dans le domaine du diagnostic.<\/li>\n<li>Les avantages des aptam\u00e8res dans le domaine du diagnostic incluent une haute sp\u00e9cificit\u00e9, une polyvalence pour diff\u00e9rents types de cibles, et une stabilit\u00e9 dans diff\u00e9rentes conditions environnementales.<\/li>\n<li>Les applications des aptam\u00e8res dans le domaine du diagnostic incluent la d\u00e9tection de biomarqueurs, les tests de proximit\u00e9, la surveillance des m\u00e9dicaments et la surveillance de l'environnement, avec le potentiel de r\u00e9volutionner les soins de sant\u00e9 et la protection de l'environnement. NeoVentures a introduit des avanc\u00e9es r\u00e9volutionnaires dans la technologie des aptam\u00e8res pour am\u00e9liorer la sensibilit\u00e9 et la s\u00e9lectivit\u00e9, renfor\u00e7ant davantage le r\u00f4le des aptam\u00e8res dans l'avenir du diagnostic.<\/li>\n<\/ul>\n<p>Dans le domaine des r\u00e9actifs de diagnostic, les aptam\u00e8res \u00e9mergent comme des outils puissants et polyvalents qui promettent de remodeler le paysage des tests m\u00e9dicaux et de la recherche. Ces minuscules mol\u00e9cules d'acides nucl\u00e9iques ou de peptides \u00e0 brin simple pr\u00e9sentent une sp\u00e9cificit\u00e9 et une affinit\u00e9 remarquables pour les mol\u00e9cules cibles, ce qui les rend inestimables dans diverses applications de diagnostic. Dans ce blog, nous plongerons dans le monde des aptam\u00e8res et explorerons comment ils sont pr\u00eats \u00e0 stimuler la prochaine g\u00e9n\u00e9ration de r\u00e9actifs de diagnostic.<\/p>\n<p><strong>Comprendre les Aptam\u00e8res<\/strong><\/p>\n<p>Les aptam\u00e8res, souvent appel\u00e9s \"anticorps chimiques\", sont des s\u00e9quences synth\u00e9tiques d'ADN, d'ARN ou de peptides \u00e0 brin simple. Leur propri\u00e9t\u00e9 unique r\u00e9side dans leur capacit\u00e9 \u00e0 se lier sp\u00e9cifiquement \u00e0 une large gamme de mol\u00e9cules cibles, notamment des prot\u00e9ines, de petites mol\u00e9cules, voire des cellules enti\u00e8res. Cette sp\u00e9cificit\u00e9 d\u00e9coule du repliement tridimensionnel des aptam\u00e8res, qui leur permet de former des interactions complexes avec leurs mol\u00e9cules cibles gr\u00e2ce \u00e0 des liaisons hydrog\u00e8ne, des interactions \u00e9lectrostatiques et des interactions hydrophobes.<\/p>\n<p><strong>Avantages des Aptam\u00e8res dans le Diagnostic<\/strong><\/p>\n<ol>\n<li><u>Haute Sp\u00e9cificit\u00e9 et Affinit\u00e9<\/u><strong>:<\/strong> Les aptam\u00e8res peuvent \u00eatre con\u00e7us pour reconna\u00eetre des cibles sp\u00e9cifiques avec une pr\u00e9cision exquise, rivalisant avec la sp\u00e9cificit\u00e9 des anticorps traditionnels. Cette caract\u00e9ristique minimise les faux positifs et am\u00e9liore la pr\u00e9cision des tests de diagnostic.<\/li>\n<li><u>Polyvalence :<\/u> Les aptam\u00e8res peuvent \u00eatre con\u00e7us pour se lier \u00e0 un large \u00e9ventail de cibles, des petites mol\u00e9cules comme les m\u00e9dicaments ou les m\u00e9tabolites aux biomol\u00e9cules complexes comme les prot\u00e9ines et les acides nucl\u00e9iques. Cette adaptabilit\u00e9 les rend id\u00e9aux pour une vari\u00e9t\u00e9 d'applications de diagnostic.<\/li>\n<li><u>Stabilit\u00e9<\/u><strong>:<\/strong> Les aptam\u00e8res sont tr\u00e8s stables et peuvent r\u00e9sister \u00e0 une gamme de conditions environnementales, y compris des temp\u00e9ratures extr\u00eames et des niveaux de pH. Cette stabilit\u00e9 garantit que les r\u00e9actifs de diagnostic incorporant des aptam\u00e8res restent fonctionnels sur des p\u00e9riodes prolong\u00e9es.<\/li>\n<\/ol>\n<p><strong>Applications des Aptam\u00e8res dans le Diagnostic<\/strong><\/p>\n<ol>\n<li><u>D\u00e9tection de Biomarqueurs :<\/u> Les aptam\u00e8res peuvent \u00eatre utilis\u00e9s pour d\u00e9tecter des biomarqueurs sp\u00e9cifiques associ\u00e9s \u00e0 des maladies telles que le cancer, les maladies infectieuses ou les troubles auto-immuns. En reconnaissant et en se liant \u00e0 ces biomarqueurs, les dosages \u00e0 base d'aptam\u00e8res permettent la d\u00e9tection pr\u00e9coce de la maladie et la surveillance.<\/li>\n<li><u>Tests de Proximit\u00e9 (POCT) :<\/u> Des dispositifs POCT \u00e0 base d'aptam\u00e8res sont en cours de d\u00e9veloppement pour des diagnostics rapides et sur site. Ces dispositifs ont le potentiel de r\u00e9volutionner les soins de sant\u00e9 en fournissant des r\u00e9sultats rapides et pr\u00e9cis sans n\u00e9cessiter d'\u00e9quipement de laboratoire sp\u00e9cialis\u00e9.<\/li>\n<li><u>Surveillance des M\u00e9dicaments :<\/u> Les aptam\u00e8res peuvent \u00eatre utilis\u00e9s pour mesurer les niveaux de m\u00e9dicaments dans le sang d'un patient, garantissant un dosage optimal des m\u00e9dicaments et minimisant le risque d'effets ind\u00e9sirables ou de r\u00e9sistance aux m\u00e9dicaments.<\/li>\n<li><u>Surveillance de l'Environnement<\/u><strong>:<\/strong> Les aptam\u00e8res trouvent \u00e9galement des applications dans la surveillance de l'environnement, o\u00f9 ils peuvent d\u00e9tecter et quantifier les polluants, les toxines et les agents pathog\u00e8nes dans l'eau et le sol, contribuant ainsi \u00e0 am\u00e9liorer la sant\u00e9 publique et la protection de l'environnement. Plus r\u00e9cemment, cela a \u00e9t\u00e9 couronn\u00e9 de succ\u00e8s dans la d\u00e9tection des agents pathog\u00e8nes. <em>Leptospira<\/em> dans les \u00e9chantillons d'eau (<a href=\"https:\/\/doi.org\/10.1038\/s41598-023-40120-w\">https:\/\/doi.org\/10.1038\/s41598-023-40120-w<\/a>).<\/li>\n<\/ol>\n<p><strong>Orientations Futures<\/strong><\/p>\n<p>NeoVentures a introduit une avanc\u00e9e r\u00e9volutionnaire dans le d\u00e9veloppement des aptam\u00e8res, r\u00e9volutionnant le paysage avec des niveaux de sensibilit\u00e9 et de s\u00e9lectivit\u00e9 in\u00e9dits. Cette innovation aborde non seulement les d\u00e9fis existants tels que l'optimisation de la stabilit\u00e9, la r\u00e9duction des co\u00fbts de production et l'am\u00e9lioration des m\u00e9thodes de livraison, mais propulse \u00e9galement les aptam\u00e8res \u00e0 de nouveaux sommets en termes de leur potentiel sur le march\u00e9.<\/p>\n<p>Dans le domaine des r\u00e9actifs de diagnostic de nouvelle g\u00e9n\u00e9ration, les aptam\u00e8res sont pr\u00eats \u00e0 jouer un r\u00f4le pivot, offrant une sp\u00e9cificit\u00e9, une adaptabilit\u00e9 et une stabilit\u00e9 in\u00e9gal\u00e9es. \u00c0 mesure que la technologie de NeoVentures continue d'\u00e9voluer, les dosages et les dispositifs \u00e0 base d'aptam\u00e8res sont sur le point de devenir des outils indispensables dans la lutte contre les maladies. Ils promettent de fournir des solutions de diagnostic plus rapides, plus pr\u00e9cises et facilement accessibles \u00e0 des individus du monde entier. Avec la technologie r\u00e9volutionnaire des aptam\u00e8res de NeoVentures, l'avenir des diagnostics brille plus que jamais, r\u00e9v\u00e9lant le potentiel remarquable que d\u00e9tiennent les aptam\u00e8res.<\/p>","protected":false},"excerpt":{"rendered":"<p>Aptamers are synthetic, single-stranded DNA, RNA, or peptide molecules with high specificity and affinity for a wide range of target molecules, making them valuable in diagnostics. Advantages of aptamers in diagnostics include high specificity, versatility for various target types, and stability under different environmental conditions. Applications of aptamers in diagnostics include biomarker detection, point-of-care testing,&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">Aptam\u00e8res : R\u00e9volutionner le Diagnostic dans la Prochaine G\u00e9n\u00e9ration<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":5553,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-5551","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aptamers: Revolutionizing Diagnostics in the Next Generation<\/title>\n<meta name=\"description\" content=\"Aptamers function as &quot;chemical antibodies,&quot; offering high specificity, stability, and versatility for revolutionizing diagnostics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptamers: Revolutionizing Diagnostics in the Next Generation\" \/>\n<meta property=\"og:description\" content=\"Aptamers function as &quot;chemical antibodies,&quot; offering high specificity, stability, and versatility for revolutionizing diagnostics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-13T16:22:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T18:31:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/10\/Blog-images3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Aptamers: Revolutionizing Diagnostics in the Next Generation\",\"datePublished\":\"2023-10-13T16:22:38+00:00\",\"dateModified\":\"2026-04-13T18:31:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/\"},\"wordCount\":642,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Blog-images3.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/\",\"name\":\"Aptamers: Revolutionizing Diagnostics in the Next Generation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Blog-images3.png\",\"datePublished\":\"2023-10-13T16:22:38+00:00\",\"dateModified\":\"2026-04-13T18:31:24+00:00\",\"description\":\"Aptamers function as \\\"chemical antibodies,\\\" offering high specificity, stability, and versatility for revolutionizing diagnostics.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Blog-images3.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Blog-images3.png\",\"width\":1000,\"height\":800,\"caption\":\"Close up of a realistic display of aptamers\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-revolutionizing-diagnostics-in-the-next-generation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptamers: Revolutionizing Diagnostics in the Next Generation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptam\u00e8res : R\u00e9volutionner le Diagnostic dans la Prochaine G\u00e9n\u00e9ration","description":"Aptamers function as \"chemical antibodies,\" offering high specificity, stability, and versatility for revolutionizing diagnostics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/","og_locale":"fr_FR","og_type":"article","og_title":"Aptamers: Revolutionizing Diagnostics in the Next Generation","og_description":"Aptamers function as \"chemical antibodies,\" offering high specificity, stability, and versatility for revolutionizing diagnostics.","og_url":"https:\/\/neoaptamers.com\/fr\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/","og_site_name":"neoaptamers","article_published_time":"2023-10-13T16:22:38+00:00","article_modified_time":"2026-04-13T18:31:24+00:00","og_image":[{"width":1000,"height":800,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/10\/Blog-images3.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Aptamers: Revolutionizing Diagnostics in the Next Generation","datePublished":"2023-10-13T16:22:38+00:00","dateModified":"2026-04-13T18:31:24+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/"},"wordCount":642,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/10\/Blog-images3.png","articleSection":["Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/","url":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/","name":"Aptam\u00e8res : R\u00e9volutionner le Diagnostic dans la Prochaine G\u00e9n\u00e9ration","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/10\/Blog-images3.png","datePublished":"2023-10-13T16:22:38+00:00","dateModified":"2026-04-13T18:31:24+00:00","description":"Aptamers function as \"chemical antibodies,\" offering high specificity, stability, and versatility for revolutionizing diagnostics.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/10\/Blog-images3.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/10\/Blog-images3.png","width":1000,"height":800,"caption":"Close up of a realistic display of aptamers"},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/aptamers-revolutionizing-diagnostics-in-the-next-generation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Aptamers: Revolutionizing Diagnostics in the Next Generation"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=5551"}],"version-history":[{"count":1,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5551\/revisions"}],"predecessor-version":[{"id":5552,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5551\/revisions\/5552"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/5553"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=5551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=5551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=5551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}